MT6-MMP is present in lipid rafts and faces inward in living human PMNs but translocates to the cell surface during neutrophil apoptosis

International Immunology

Volumn 22, Issue 8, 2010, Pages 637-649

  Fortin, Carl F ^a   Sohail, Anjum ^b   Sun, Qing ^b   McDonald, Patrick P ^a   Fridman, Rafael ^b   Fülöp, Tamàs ^c  

^a UNIVERSITY OF SHERBROOKE   (Canada)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY INSTITUTE OF GERIATRICS OF SHERBROOKE   (Canada)

Author keywords

Apoptosis; Chemotaxis; Cytokines; Lipid rafts; Matrix metalloproteinase; Neutrophils

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 8; LIPOCORTIN 5; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE MEMBRANE TYPE 6; TISSUE INHIBITOR OF METALLOPROTEINASE 2; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL CULTURE; CELL FRACTIONATION; CELL ISOLATION; CELL STIMULATION; CELL SURFACE; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME RELEASE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOPRECIPITATION; LIPID RAFT; NEUTROPHIL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RESPIRATORY BURST;

APOPTOSIS; CELLS, CULTURED; GPI-LINKED PROTEINS; HUMANS; IMMUNOBLOTTING; MATRIX METALLOPROTEINASES, MEMBRANE-ASSOCIATED; MEMBRANE MICRODOMAINS; MICROSCOPY, CONFOCAL; NEUTROPHILS; PROTEIN TRANSPORT; TISSUE INHIBITOR OF METALLOPROTEINASE-2;

EID: 77955039982     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxq048     Document Type: Article

References (42)

1. Serhan, C. N. and Savill, J. 2005. Resolution of inflammation: the beginning programs the end. Nat. Immunol. 6:1191.
2. Ren, Y., Xie, Y., Jiang, G. et al. 2008. Apoptotic cells protect mice against lipopolysaccharide-induced shock. J. Immunol. 180:4978.
3. Maslinska, D. and Gajewski, M. 1998. Some aspects of the inflammatory process. Folia Neuropathol. 36:199.
4. Nathan, C. 2006. Neutrophils and immunity: challenges and opportunities. Nat. Rev. Immunol. 6:173.
5. Scapini, P., Lapinet-Vera, J. A., Gasperini, S., Calzetti, F., Bazzoni, F. and Cassatella, M. A. 2000. The neutrophil as a cellular source of chemokines. Immunol. Rev. 177:195.
6. Kasama, T., Miwa, Y., Isozaki, T., Odai, T., Adachi, M. and Kunkel, S. L. 2005. Neutrophil-derived cytokines: potential therapeutic targets in inflammation. Curr. Drug Targets Inflamm. Allergy 4:273.
7. Scapini, P., Carletto, A., Nardelli, B. et al. 2005. Proinflammatory mediators elicit secretion of the intracellular B-lymphocyte stimulator pool (BLyS) that is stored in activated neutrophils: implications for inflammatory diseases. Blood 105:830.
8. Borregaard, N., Sorensen, O. E. and Theilgaard-Monch, K. 2007. Neutrophil granules: a library of innate immunity proteins. Trends Immunol. 28:340.
9. Opdenakker, G., Van den Steen, P. E., Dubois, B. et al. 2001. Gelatinase B functions as regulator and effector in leukocyte biology. J. Leukoc. Biol. 69:851.
10. Van Lint, P. and Libert, C. 2006. Matrix metalloproteinase-8: cleavage can be decisive. Cytokine Growth Factor Rev. 17:217.
11. Kang, T., Yi, J., Guo, A. et al. 2001. Subcellular distribution and cytokine and chemokine-regulated secretion of leukolysin/MT6-MMP/MMP-25 in neutrophils. J. Biol. Chem. 276:21960.
12. Pei, D. 1999. Leukolysin/MMP25/MT6-MMP: a novel matrix metalloproteinase specifically expressed in the leukocyte lineage. Cell Res. 9:291.
13. Sun, Q., Weber, C. R., Sohail, A. et al. 2007. MMP25 (MT6-MMP) is highly expressed in human colon cancer, promotes tumor growth, and exhibits unique biochemical properties. J. Biol. Chem. 282:21998.
14. Zhao, H., Sohail, A., Sun, Q. et al. 2008. Identification and role of the homodimerization interface of the glycosylphosphatidylinositol anchored membrane type 6 matrix metalloproteinase (MMP25). J. Biol. Chem. 283:35023.
15. Nebl, T., Pestonjamasp, K. N., Leszyk, J. D., Crowley, J. L., Oh, S. W. and Luna, E. J. 2002. Proteomic analysis of a detergent resistant membrane skeleton from neutrophil plasma membranes. J. Biol. Chem. 277:43399.
16. Matsuda, A., Itoh, Y., Koshikawa, N., Akizawa, T., Yana, I. and Seiki, M. 2003. Clusterin, an abundant serum factor, is a possible negative regulator of MT6-MMP/MMP-25 produced by neutrophils. J. Biol. Chem. 278:36350.
17. Nie, J. and Pei, D. 2004. Rapid inactivation of alpha-1-proteinase inhibitor by neutrophil specific leukolysin/membrane-type matrix metalloproteinase 6. Exp. Cell Res. 296:145.
18. Boyum, A. 1968. Isolation of mononuclear cells and granulocytes from human blood. Isolation of mononuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand. J. Clin. Lab. Invest. 97 (Suppl.):77.
19. Ear, T., Cloutier, A. and McDonald, P. P. 2005. Constitutive nuclear expression of the I kappa B kinase complex and its activation in human neutrophils. J. Immunol. 175:1834.
20. Fortin, C. F., Larbi, A., Lesur, O., Douziech, N. and Fulop, T. Jr. 2006. Impairment of SHP-1 down-regulation in the lipid rafts of human neutrophils under GM-CSF stimulation contributes to their age-related, altered functions. J. Leukoc. Biol. 79:1061.
21. Fortin, C. F., Lesur, O. and Fulop, T. Jr. 2007. Effects of TREM-1 activation in human neutrophils: activation of signaling pathways, recruitment into lipid rafts and association with TLR4. Int. Immunol. 19:41.
22. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680.
23. English, W. R., Velasco, G., Stracke, J. O., Knauper, V. and Murphy, G. 2001. Catalytic activities of membrane-type 6 matrix metalloproteinase (MMP25). FEBS Lett. 491:137.
24. Sohail, A., Sun, Q., Zhao, H., Bernardo, M. M., Cho, J. A. and Fridman, R. 2008. MT4-(MMP17) and MT6-MMP (MMP25), a unique set of membrane-anchored matrix metalloproteinases: properties and expression in cancer. Cancer Metastasis Rev. 27:289.
25. Opdenakker, G., Masure, S., Grillet, B. and Van Damme, J. 1991. Cytokine-mediated regulation of human leukocyte gelatinases and role in arthritis. Lymphokine Cytokine Res. 10:317.
26. Masure, S., Proost, P., Van Damme, J. and Opdenakker, G. 1991. Purification and identification of 91-kDa neutrophil gelatinase. Release by the activating peptide interleukin-8. Eur. J. Biochem. 198:391.
27. Sitrin, R. G., Emery, S. L., Sassanella, T. M., Blackwood, R. A. and Petty, H. R. 2006. Selective localization of recognition complexes for leukotriene B4 and formyl-Met-Leu-Phe within lipid raft micro domains of human polymorphonuclear neutrophils. J. Immunol. 177:8177.
28. Blank, N., Schiller, M., Krienke, S., Wabnitz, G., Ho, A. D. and Lorenz, H. M. 2007. Cholera toxin binds to lipid rafts but has a limited specificity for ganglioside GM1. Immunol. Cell Biol. 85:378.
29. Fernandez-Segura, E., Garcia, J. M., Lopez-Escamez, J. A. and Campos, A. 1994. Surface expression and distribution of Fc receptor III (CD16 molecule) on human natural killer cells and polymorphonuclear neutrophils. Microsc. Res. Tech. 28:277.
30. Park, H. Y., Jin, J. O., Song, M. G., Park, J. I. and Kwak, J. Y. 2007. Expression of dendritic cell markers on cultured neutrophils and its modulation by anti-apoptotic and pro-apoptotic compounds. Exp. Mol. Med. 39:439.
31. Shao, D., Segal, A. W. and Dekker, L. V. 2003. Lipid rafts determine efficiency of NADPH oxidase activation in neutrophils. FEBS Lett. 550:101.
32. 2 generation by human neutrophils. Mol. Immunol. 41:185.
33. Yanagida, M., Nakayama, H., Yoshizaki, F. et al. 2007. Proteomic analysis of plasma membrane lipid rafts of HL-60 cells. Proteomics 7:2398.
34. Yoshizaki, F., Nakayama, H., Iwahara, C., Takamori, K., Ogawa, H. and Iwabuchi, K. 2008. Role of glycosphingolipid-enriched microdomains in innate immunity: microdomain-dependent phagocytic cell functions. Biochim. Biophys. Acta 1780:383.
35. Nakayama, H., Yoshizaki, F., Prinetti, A. et al. 2008. Lyn-coupled LacCer-enriched lipid rafts are required for CD11b/CD18-mediated neutrophil phagocytosis of nonopsonized microorganisms. J. Leukoc. Biol. 83:728.
36. David, A., Fridlich, R. and Aviram, I. 2005. The presence of membrane proteinase 3 in neutrophil lipid rafts and its colocalization with FcgammaRIIIb and cytochrome b558. Exp. Cell Res. 308:156.
37. Fulop, T., Larbi, A., Douziech, N. et al. 2004. Signal transduction and functional changes in neutrophils with aging. Aging Cell. 3:217.
38. Avdi, N. J., Nick, J. A., Whitlock, B. B. et al. 2001. Tumor necrosis factor-alpha activation of the c-Jun N-terminal kinase pathway in human neutrophils. Integrin involvement in a pathway leading from cytoplasmic tyrosine kinases apoptosis. J. Biol. Chem. 276:2189.
39. Wize, J., Sopata, I., Smerdel, A. and Maslinski, S. 1998. Ligation of selectin L and integrin CD11b/CD18 (Mac-1) induces release of gelatinase B (MMP-9) from human neutrophils. Inflamm. Res. 47:325.
40. Kennedy, A. D. and DeLeo, F. R. 2009. Neutrophil apoptosis and the resolution of infection. Immunol. Res. 43:25.
41. Xia, M., Leppert, D., Hauser, S. L. et al. 1996. Stimulus specificity of matrix metalloproteinase dependence of human T cell migration through a model basement membrane. J. Immunol. 156:160.
42. Mackarel, A. J., Cottell, D. C., Russell, K. J., FitzGerald, M. X. and O'Connor, C. M. 1999. Migration of neutrophils across human pulmonary endothelial cells is not blocked by matrix metal loproteinase or serine protease inhibitors. Am. J. Respir. Cell Mol. Biol. 20:1209.